p21-activated kinase 4 regulation of endometrial cancer cell migration and invasion involves the ERK1/2 pathway mediated MMP-2 secretion

Neoplasma

Volumn 60, Issue 5, 2013, Pages 493-503

  Lu, W ^a   Xia, Y H ^a   Qu, J J ^a   He, Y Y ^a   Li, B L ^a   Lu, C ^a   Luo, X ^a   Wan, X P ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Endometrial cancer (EC); ERK1 2; Invasion; Metastasis; Migration; MMP 2; P21 activated kinase 4 (Pak4)

Indexed keywords

GELATINASE A; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; P21 ACTIVATED KINASE 4; P21 ACTIVATED KINASE; PAK4 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR GROWTH; WESTERN BLOTTING; CELL MOTION; ENDOMETRIUM TUMOR; GENETIC TRANSFECTION; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SECRETION (PROCESS); TUMOR CELL LINE; TUMOR INVASION;

ADULT; AGED; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; ENDOMETRIAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; NEOPLASM INVASIVENESS; P21-ACTIVATED KINASES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 84891666772     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2013_064     Document Type: Article

References (45)

1. SIEGEL R, WARD E, BRAWLEY O, JEMAL A. Cancer statistics, 2011. CA: A Cancer Journal for Clinicians 2011; 61: 212-236. http://dx.doi.org/10.3322/caac.20121
2. WANG D, ZHENG W, WANG S-M, WANG J-B, WEI W-Q et al. Estimation of Cancer Incidence and Mortality Attributable to Overweight, Obesity, and Physical Inactivity in China. Nutrition and Cancer 2012; 64: 48-56. http://dx.doi.org/10.1080/01635581.2012.630166
3. DEDES KJ, WETTERSKOG D, ASHWORTH A, KAYE SB, REIS-FILHO JS. Emerging therapeutic targets in endometrial cancer. Nature Reviews Clinical Oncology 2011; 8: 261-271. http://dx.doi.org/10.1038/nrclinonc.2010.216
4. LEE NK. Adjuvant treatment of advanced-stage endometrial cancer. Clin Obstet Gynecol 2011; 54: 256-265. http://dx.doi.org/10.1097/GRF.0b013e318218c659
5. KUMAR R, GURURAJ AE, BARNES CJ. p21-activated kinases in cancer. Nature Reviews Cancer 2006; 6: 459-471. http://dx.doi.org/10.1038/nrc1892
6. WHALE A, HASHIM FN, FRAM S, JONES GE, WELLS CM. Signalling to cancer cell invasion through PAK family kinases. Front Biosci 2011; 16: 849-864. http://dx.doi.org/10.2741/3724
7. ESWARAN J, SOUNDARARAJAN M, KUMAR R, KNAPP S. UnPAKing the class differences among p21-activated kinases. Trends in Biochemical Sciences 2008; 33: 394-403. http://dx.doi.org/10.1016/j.tibs.2008.06.002
8. BASKARAN Y, NG YW, SELAMAT W, LING FT, MANSER E. Group I and II mammalian PAKs have different modes of activation by Cdc42. EMBO Rep 2012; 13: 653-659. http://dx.doi.org/10.1038/embor.2012.75
9. DUMMLER B, OHSHIRO K, KUMAR R, FIELD J. Pak protein kinases and their role in cancer. Cancer and Metastasis Reviews 2009; 28: 51-63. http://dx.doi.org/10.1007/s10555-008-9168-1
10. ABO A, QU J, CAMMARANO MS, DAN C, FRITSCH A et al. PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia. EMBO J 1998; 17: 6527-6540. http://dx.doi.org/10.1093/emboj/17.22.6527
11. BARAC A, BASILE J, VAZQUEZ-PRADO J, GAO Y, ZHENG Y et al. Direct interaction of p21-activated kinase 4 with PDZRhoGEF, a G protein-linked Rho guanine exchange factor. J Biol Chem 2004; 279: 6182-6189. http://dx.doi.org/10.1074/jbc.M309579200
12. CALLOW MG, ZOZULYA S, GISHIZKY ML, JALLAL B, SMEAL T. PAK4 mediates morphological changes through the regulation of GEF-H1. J Cell Sci 2005; 118: 1861-1872. http://dx.doi.org/10.1242/jcs.02313
13. ZHANG H, LI Z, VIKLUND EK, STROMBLAD S. P21-activated kinase 4 interacts with integrin alpha v beta 5 and regulates alpha v beta 5-mediated cell migration. J Cell Biol 2002; 158: 1287-1297. http://dx.doi.org/10.1083/jcb.200207008
14. LI Z, LOCK JG, OLOFSSON H, KOWALEWSKI JM, TELLER S et al. Integrin-mediated cell attachment induces a PAK4-dependent feedback loop regulating cell adhesion through modified integrin alpha v beta 5 clustering and turnover. Mol Biol Cell 2010; 21: 3317-3329. http://dx.doi.org/10.1091/mbc.E10-03-0245
15. SOOSAIRAJAH J, MAITI S, WIGGAN O, SARMIERE P, MOUSSI N et al. Interplay between components of a novel LIM kinase-slingshot phosphatase complex regulates cofilin. EMBO J 2005; 24: 473-486. http://dx.doi.org/10.1038/sj.emboj.7600543
16. DAN C, KELLY A, BERNARD O, MINDEN A. Cytoskeletal changes regulated by the PAK4 serine/threonine kinase are mediated by LIM kinase 1 and cofilin. J Biol Chem 2001; 276: 32115-32121. http://dx.doi.org/10.1074/jbc.M100871200
17. AHMED T, SHEA K, MASTERS JRW, JONES GE, WELLS CM. A PAK4-LIMK1 pathway drives prostate cancer cell migration downstream of HGF. Cellular Signalling 2008; 20: 1320-1328. http://dx.doi.org/10.1016/j.cellsig.2008.02.021
18. SIU MK, CHAN HY, KONG DS, WONG ES, WONG OG et al. p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients. Proc Natl Acad Sci U S A 2010; 107: 18622-18627. http://dx.doi.org/10.1073/pnas.0907481107
19. ZHANG HJ, SIU MK, YEUNG MC, JIANG LL, MAK VC et al. Overexpressed PAK4 promotes proliferation, migration and invasion of choriocarcinoma. Carcinogenesis 2011; 32: 765-771. http://dx.doi.org/10.1093/carcin/bgr033
20. CALLOW MG. Requirement for PAK4 in the Anchorageindependent Growth of Human Cancer Cell Lines. Journal of Biological Chemistry 2001; 277: 550-558. http://dx.doi.org/10.1074/jbc.M105732200
21. LI X, KE Q, LI Y, LIU F, ZHU G et al. DGCR6L, a novel PAK4 interaction protein, regulates PAK4-mediated migration of human gastric cancer cell via LIMK1. Int J Biochem Cell Biol 2010; 42: 70-79. http://dx.doi.org/10.1016/j.biocel.2009.09.008
22. MAK GW, CHAN MM, LEONG VY, LEE JM, YAU TO et al. Overexpression of a novel activator of PAK4, the CDK5 kinase-associated protein CDK5RAP3, promotes hepatocellular carcinoma metastasis. Cancer Res 2011; 71: 2949-2958. http://dx.doi.org/10.1158/0008-5472.CAN-10-4046
23. LIU Y, XIAO H, TIAN Y, NEKRASOVA T, HAO X et al. The Pak4 Protein Kinase Plays a Key Role in Cell Survival and Tumorigenesis in Athymic Mice. Molecular Cancer Research 2008; 6: 1215-1224. http://dx.doi.org/10.1158/1541-7786.MCR-08-0087
24. ZHANG L, REES MC, BICKNELL R. The isolation and longterm culture of normal human endometrial epithelium and stroma. Expression of mRNAs for angiogenic polypeptides basally and on oestrogen and progesterone challenges. J Cell Sci 1995; 108 (Pt 1): 323-331.
25. OSTEEN KG, HILL GA, HARGROVE JT, GORSTEIN F. Development of a method to isolate and culture highly purified populations of stromal and epithelial cells from human endometrial biopsy specimens. Fertil Steril 1989; 52: 965-972.
26. NISHIDA M. The Ishikawa cells from birth to the present. Hum Cell 2002; 15: 104-117. http://dx.doi.org/10.1111/j.1749-0774.2002.tb00105.x
27. DAWE CJ, BANFIELD WG, MORGAN WD, SLATICK MS, CURTH HO. Growth in Continuous Culture, and in Hamsters, of Cells from a Neoplasm Associated with Acanthosis Nigricans. J Natl Cancer Inst 1964; 33: 441-456.
28. PARK MH, LEE HS, LEE CS, YOU ST, KIM DJ et al. p21-Activated kinase 4 promotes prostate cancer progression through CREB. Oncogene 2012.
29. CREASMAN WT, MORROW CP, BUNDY BN, HOMESLEY HD, GRAHAM JE et al. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 1987; 60: 2035-2041. http://dx.doi.org/10.1002/1097-0142(19901015)60:8+<2035::AIDCNCR2820601515>3.0.CO;2-8
30. CREASMAN W. Revised FIGO staging for carcinoma of the endometrium. International Journal of Gynecology & Obstetrics 2009; 105: 109. http://dx.doi.org/10.1016/j.ijgo.2009.02.010
31. UHARCEK P. Prognostic factors in endometrial carcinoma. Journal of Obstetrics and Gynaecology Research 2008; 34: 776-783. http://dx.doi.org/10.1111/j.1447-0756.2008.00796.x
32. DI CRISTOFANO A, ELLENSON LH. Endometrial Carcinoma. Annual Review of Pathology: Mechanisms of Disease 2007; 2: 57-85. http://dx.doi.org/10.1146/annurev.pathol.2.010506.091905
33. LEE SR. AR and ER Interaction with a p21-Activated Kinase (PAK6). Molecular Endocrinology 2002; 16: 85-99. http://dx.doi.org/10.1210/me.16.1.85
34. GURURAJ AE. Novel Mechanisms of Resistance to Endocrine Therapy: Genomic and Nongenomic Considerations. Clinical Cancer Research 2006; 12: 1001s-1007s. http://dx.doi.org/10.1158/1078-0432.CCR-05-2110
35. WELLS CM. PAK4 is activated via PI3K in HGF-stimulated epithelial cells. Journal of Cell Science 2002; 115: 3947-3956. http://dx.doi.org/10.1242/jcs.00080
36. QU J, CAMMARANO MS, SHI Q, HA KC, de LANEROLLE P et al. Activated PAK4 regulates cell adhesion and anchorage-independent growth. Mol Cell Biol 2001; 21: 3523-3533. http://dx.doi.org/10.1128/MCB.21.10.3523-3533.2001
37. LI Z, LOCK JG, OLOFSSON H, KOWALEWSKI JM, TELLER S et al. Integrin-mediated Cell Attachment Induces a PAK4-dependent Feedback Loop Regulating Cell Adhesion through Modified Integrin v 5 Clustering and Turnover. Molecular Biology of the Cell 2010; 21: 3317-3329. http://dx.doi.org/10.1091/mbc.E10-03-0245
38. QU J, LI X, NOVITCH BG, ZHENG Y, KOHN M et al. PAK4 kinase is essential for embryonic viability and for proper neuronal development. Mol Cell Biol 2003; 23: 7122-7133. http://dx.doi.org/10.1128/MCB.23.20.7122-7133.2003
39. HOOD JD, CHERESH DA. Role of Integrins in Cell Invasion and Migration. Nature Reviews Cancer 2002; 2: 91-100. http://dx.doi.org/10.1038/nrc727
40. DECOCK J, THIRKETTLE S, WAGSTAFF L, EDWARDS DR. Matrix metalloproteinases: protective roles in cancer. J Cell Mol Med 2011; 15: 1254-1265. http://dx.doi.org/10.1111/j.1582-4934.2011.01302.x
41. THULLBERG M, GAD A, BEESER A, CHERNOFF J, STROMBLAD S. The kinase-inhibitory domain of p21-activated kinase 1 (PAK1) inhibits cell cycle progression independent of PAK1 kinase activity. Oncogene 2007; 26: 1820-1828. http://dx.doi.org/10.1038/sj.onc.1209983
42. CHAUDHRY P, ASSELIN E. Resistance to chemotherapy and hormone therapy in endometrial cancer. Endocrine Related Cancer 2009; 16: 363-380. http://dx.doi.org/10.1677/ERC-08-0266
43. LI X. PAK4 Functions in Tumor Necrosis Factor (TNF)-induced Survival Pathways by Facilitating TRADD Binding to the TNF Receptor. Journal of Biological Chemistry 2005; 280: 41192-41200. http://dx.doi.org/10.1074/jbc.M506884200
44. GNESUTTA N, QU J, MINDEN A. The serine/threonine kinase PAK4 prevents caspase activation and protects cells from apoptosis. J Biol Chem 2001; 276: 14414-14419.
45. ONG CC, JUBB AM, HAVERTY PM, ZHOU W, TRAN V et al. Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells. Proceedings of the National Academy of Sciences 2011; 108: 7177-7182. http://dx.doi.org/10.1073/pnas.1103350108